Literature DB >> 8501219

Expression of hemolytic activity by Plesiomonas shigelloides.

J M Janda1, S L Abbott.   

Abstract

More than 90% of the Plesiomonas shigelloides strains that we tested produced a beta-hemolysin, as judged by the results of agar overlay and contact-dependent hemolysis assays. The hemolysin was cell associated, was active against the erythrocytes of various animal species, and was synthesized at both 25 and 35 degrees C. Activity was lost after thermal or proteolytic treatments or after preincubation in the presence of gentamicin; hemolytic activity did not appear to correlate with the previously established 50% lethal doses for seven of these strains. The hemolysin may play a role in iron acquisition in vivo via the lysis of erythrocytes, liberating hemoglobin, or, alternatively, may be involved in gastrointestinal disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501219      PMCID: PMC262904          DOI: 10.1128/jcm.31.5.1206-1208.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Plesiomonas enteric infections in the United States.

Authors:  S D Holmberg; I K Wachsmuth; F W Hickman-Brenner; P A Blake; J J Farmer
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

2.  In vitro and in vivo pathogenicity of Plesiomonas shigelloides.

Authors:  D A Herrington; S Tzipori; R M Robins-Browne; B D Tall; M M Levine
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

3.  In vitro production of cholera toxin-like activity by Plesiomonas shigelloides.

Authors:  S E Gardner; S E Fowlston; W L George
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

4.  Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis.

Authors:  P J Sansonetti; A Ryter; P Clerc; A T Maurelli; J Mounier
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  Intestinal secretory immune response to infection with Aeromonas species and Plesiomonas shigelloides among students from the United States in Mexico.

Authors:  Z D Jiang; A C Nelson; J J Mathewson; C D Ericsson; H L DuPont
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

Review 6.  Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans.

Authors:  R A Brenden; M A Miller; J M Janda
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

7.  Penetration and replication of Edwardsiella spp. in HEp-2 cells.

Authors:  J M Janda; S L Abbott; L S Oshiro
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Iron-Binding Catechols and Virulence in Escherichia coli.

Authors:  H J Rogers
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

9.  Laboratory investigations on the low pathogenic potential of Plesiomonas shigelloides.

Authors:  S L Abbott; R P Kokka; J M Janda
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Iron uptake in Plesiomonas shigelloides: cloning of the genes for the heme-iron uptake system.

Authors:  P A Daskaleros; J A Stoebner; S M Payne
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

View more
  10 in total

1.  Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system.

Authors:  C Theodoropoulos; T H Wong; M O'Brien; D Stenzel
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 2.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Phenotypic characterization and putative virulence factors of human, animal and environmental isolates of Plesiomonas shigelloides.

Authors:  A Salerno; I Cižnár; K Krovacek; M Conte; S Dumontet; C González-Rey; V Pasquale
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

4.  Potential virulence-associated properties of Plesiomonas shigelloides strains.

Authors:  I Ciznár; A Hostacka; C Gonzalez-Rey; K Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Some properties of Plesiomonas shigelloides treated with aminoglycosides.

Authors:  A Hostacká; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

6.  Rapid and sensitive detection of Plesiomonas shigelloides by cross‑priming amplification of the hugA gene.

Authors:  Shuang Meng; Yi Wang; Yan Wang; Changyun Ye
Journal:  Mol Med Rep       Date:  2016-11-14       Impact factor: 2.952

7.  NMR study of the O-specific polysaccharide and the core oligosaccharide from the lipopolysaccharide produced by Plesiomonas shigelloides O24:H8 (strain CNCTC 92/89).

Authors:  Lena C E Lundqvist; Marta Kaszowska; Corine Sandström
Journal:  Molecules       Date:  2015-04-01       Impact factor: 4.411

8.  Structural Studies of the Lipopolysaccharide Isolated from Plesiomonas shigelloides O22:H3 (CNCTC 90/89).

Authors:  Anna Maciejewska; Brygida Bednarczyk; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

9.  Rapid and sensitive detection of Plesiomonas shigelloides by loop-mediated isothermal amplification of the hugA gene.

Authors:  Shuang Meng; Jianguo Xu; Yanwen Xiong; Changyun Ye
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  Clostridium perfringens meningitis, Plesiomonas shigelloides sepsis: A lethal combination.

Authors:  Emmanuel Okon; Eliahu Bishburg; Sandra Ugras; Trini Chan; He Wang
Journal:  Am J Case Rep       Date:  2013-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.